Skip Navigation

JNCI Journal of the National Cancer Institute 2004 96(11):888-889; doi:10.1093/jnci/djh175
© 2004 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Hrushesky, W. J. M.
Right arrow Articles by Blask, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hrushesky, W. J. M.
Right arrow Articles by Blask, D. E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 Oxford University Press

CORRESPONDENCE

Re: Melatonin and Breast Cancer: A Prospective Study

William J. M. Hrushesky, David E. Blask

Affiliations of authors: Medical Chronobiology Laboratory, WJB Dorn VAMC, and the University of South Carolina, 6439 Garners Ferry Rd., Columbia (WJMH); Laboratory of Chrono-Neuroendocrine Oncology, Bassett Research Institute, Cooperstown, NY (DEB)

Correspondence to: William J. M. Hrushesky, MD, Medical Chronobiology Laboratory, WJB Dorn VAMC and the University of South Carolina, 6439 Garners Ferry Rd., Columbia, SC 29210 (e-mail: william.hrushesky@med.va.gov)

The first 10% of the full text of this article appears below.

The recent paper by Travis et al. (1) describing 24-hour urinary melatonin metabolite excretion among women in the Guernsey cohort study, who have or have not developed breast cancer since 1985, requires two specific comments. In general, this is a solid study considering the impact of most known modulators of breast cancer risk and the . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
E. S. Schernhammer and S. E. Hankinson
Urinary Melatonin Levels and Postmenopausal Breast Cancer Risk in the Nurses' Health Study Cohort
Cancer Epidemiol. Biomarkers Prev., January 1, 2009; 18(1): 74 - 79.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
D. K. Mirick and S. Davis
Melatonin as a Biomarker of Circadian Dysregulation
Cancer Epidemiol. Biomarkers Prev., December 1, 2008; 17(12): 3306 - 3313.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
E. S. Schernhammer, F. Berrino, V. Krogh, G. Secreto, A. Micheli, E. Venturelli, S. Sieri, C. T. Sempos, A. Cavalleri, H. J. Schunemann, et al.
Urinary 6-Sulfatoxymelatonin Levels and Risk of Breast Cancer in Postmenopausal Women
J Natl Cancer Inst, June 18, 2008; 100(12): 898 - 905.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
E. S. O'Leary, E. R. Schoenfeld, R. G. Stevens, G. C. Kabat, K. Henderson, R. Grimson, M. D. Gammon, M. C. Leske, and for the Electromagnetic Fields and Breast Cancer o
Shift Work, Light at Night, and Breast Cancer on Long Island, New York
Am. J. Epidemiol., August 15, 2006; 164(4): 358 - 366.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
E. S. Schernhammer and S. E. Hankinson
Urinary Melatonin Levels and Breast Cancer Risk
J Natl Cancer Inst, July 20, 2005; 97(14): 1084 - 1087.
[Abstract] [Full Text] [PDF]